[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

Search Results (264)

Search Parameters:
Keywords = parental active mediation

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 3907 KiB  
Article
Model-Informed Dose Optimization of Spironolactone in Neonates and Infants
by Amira Soliman, Leandro F. Pippa, Jana Lass, Stephanie Leroux, Valvanera Vozmediano and Natalia V. de Moraes
Pharmaceuticals 2025, 18(3), 355; https://doi.org/10.3390/ph18030355 - 1 Mar 2025
Viewed by 396
Abstract
Background/Objectives: Spironolactone (SP) has been used off-label in pediatrics since its approval, but its use is challenged by limited pharmacokinetic (PK) data in adults and especially in children. Methods: Physiologically based pharmacokinetic (PBPK) models for SP and its active metabolites, canrenone [...] Read more.
Background/Objectives: Spironolactone (SP) has been used off-label in pediatrics since its approval, but its use is challenged by limited pharmacokinetic (PK) data in adults and especially in children. Methods: Physiologically based pharmacokinetic (PBPK) models for SP and its active metabolites, canrenone (CAN) and 7α thio-methyl spironolactone (TMS), in adults were developed. These models aim to enhance understanding of SP’s PK and provide a basis for predicting PK and optimizing SP dosing in infants and neonates. Given SP’s complex metabolism, we assumed complete conversion to CAN and TMS by CES1 enzymes, fitting CES1-mediated metabolism to the parent-metabolite model using PK data. We incorporated ontogeny for CES1 and CYP3A4 and other age-related physiological changes into the model to anticipate PK in the pediatric population. Results: The PBPK models for SP, CAN, and TMS accurately captured the observed PK data in healthy adults across various dosing regimens, including the impact of food on drug exposure. The pediatric PBPK model was evaluated using PK data from infants and neonates. Simulations indicate that 2.5 mg/kg in 6-month to 2-year infants and 2 mg/kg in 1–6-months infants matched the total unbound systemic exposure equivalent to the standard recommended daily maintenance dose of 100 mg in adults for treating edema. Conclusions: The developed PBPK model provides valuable insights for dosing decisions and optimizing therapeutic outcomes, especially in populations where clinical studies are challenging. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>A systematic PBPK modeling workflow was used to predict exposure to spironolactone and its active metabolites in pediatric patients. The model was pragmatically developed and validated in adults before being scaled to the pediatric population. This approach supports dosing recommendations of oral spironolactone for term neonates up to infants aged 2 years. TMS: 7α-thiomethylspironolactone; CAN: canrenone.</p>
Full article ">Figure 2
<p>Schematic diagram showing the initial steps of the two main pathways of biotransformation of spironolactone in the human liver (<b>A</b>) and the simplified metabolic pathway proposed for modeling purposes (<b>B</b>). Only the compounds included in the PBPK model were added to panel B. Panel A is adapted from Varin et al., 1992 [<a href="#B26-pharmaceuticals-18-00355" class="html-bibr">26</a>]. CES1: carboxylesterases1; PON3: Paroxonase3.</p>
Full article ">Figure 3
<p>PBPK model development; predicted versus observed plasma concentrations versus time obtained after oral administration of 200 mg of spironolactone tablets for spironolactone (red), canrenone (blue), and TMS (green). Observed data; Overdiek et al. study [<a href="#B17-pharmaceuticals-18-00355" class="html-bibr">17</a>]. The solid lines represent the population means, and the shaded area is the 90% population prediction interval. Observed data are shown as circles representing the mean values.</p>
Full article ">Figure 4
<p>Goodness-of-fit (GoF) plots of AUC<sub>0–last</sub> and C<sub>max</sub> predicted versus observed pharmacokinetic metrics for spironolactone (<b>A</b>), canrenone (<b>B</b>), and 7α-thiomethyl spironolactone (<b>C</b>) in adults [<a href="#B7-pharmaceuticals-18-00355" class="html-bibr">7</a>,<a href="#B8-pharmaceuticals-18-00355" class="html-bibr">8</a>,<a href="#B10-pharmaceuticals-18-00355" class="html-bibr">10</a>,<a href="#B18-pharmaceuticals-18-00355" class="html-bibr">18</a>,<a href="#B19-pharmaceuticals-18-00355" class="html-bibr">19</a>,<a href="#B20-pharmaceuticals-18-00355" class="html-bibr">20</a>,<a href="#B21-pharmaceuticals-18-00355" class="html-bibr">21</a>,<a href="#B22-pharmaceuticals-18-00355" class="html-bibr">22</a>,<a href="#B23-pharmaceuticals-18-00355" class="html-bibr">23</a>,<a href="#B24-pharmaceuticals-18-00355" class="html-bibr">24</a>]. The line of identity is shown as a solid line; the 1.25-fold deviation is shown as a dotted line; the 2-fold deviation is shown as a dashed line. AUC<sub>last</sub>: area under the plasma concentration–time curve from the first to the last data point, C<sub>max</sub>: maximum plasma concentration.</p>
Full article ">Figure 5
<p>PBPK Model validation in pediatrics. Predicted versus observed plasma concentrations over time obtained after oral administration of 1 mg/kg of spironolactone suspension for spironolactone (red), canrenone (blue), and TMS (green). Observed data; Lass et al. [<a href="#B14-pharmaceuticals-18-00355" class="html-bibr">14</a>]. The solid lines represent the population median, and the shaded areas represent the 90% population prediction interval. Observed data are shown as circles representing the median with error bars representing the 25–75th percentiles range.</p>
Full article ">Figure 6
<p>Simulations in infants (older infants: 6 months to 2 years old) (younger infants: 1 month to 6 months old) and neonates (birth to 1 month old), on day 7th following spironolactone 1–3 mg/kg doses (in 0.5 mg increments), administered once daily as an oral suspension, compared to adult exposure to (<b>A</b>) starting dose of 50 mg and (<b>B</b>) maintenance dose of 100 mg. The total exposure is defined as the unbound plasma AUC of SP, CAN, and TMS normalized by relative potencies of the active metabolites relative to the parent compound.</p>
Full article ">
15 pages, 231 KiB  
Article
Voices of Children with Cancer and Their Siblings in the Family Talk Intervention
by Maria Ayoub, Malin Lövgren, Ulrika Kreicbergs and Camilla Udo
Children 2025, 12(3), 266; https://doi.org/10.3390/children12030266 - 21 Feb 2025
Viewed by 321
Abstract
Background: Children in pediatric oncology report unmet needs related to communication and information about the illness, care involvement, and psychosocial support. Supporting the whole family involves challenges, with a risk that children’s voices are not heard above those of the adults. Article 12 [...] Read more.
Background: Children in pediatric oncology report unmet needs related to communication and information about the illness, care involvement, and psychosocial support. Supporting the whole family involves challenges, with a risk that children’s voices are not heard above those of the adults. Article 12 of the UNCRC has been a catalyst in supporting children’s voices and their right to participate in processes that affect them. The aim of this study was to explore how children with cancer and their siblings experienced participation in a family-centered psychosocial support intervention, the Family Talk Intervention (FTI). Methods: Interviews were held with 35 children (ill and siblings) from 26 families in pediatric oncology after having completed the FTI. A combined deductive and inductive qualitative content analysis was undertaken, guided by the Lundy model of child participation. Results: Children’s experiences of being able to express their views, being listened to, and being involved during FTI were mainly positive. This was related to their participation in individual meetings where they could raise their concerns and views, undertake small activities while talking, and have their voices and needs mediated to relevant adults, such as parents and professionals. Conclusions: The findings of this study showed that the FTI for families in pediatric oncology created opportunities to promote child participation. These findings indicate that, by offering children an individual space where they can express themselves freely and supporting them in various ways to do so, the children’s voices and involvement are strengthened. Full article
13 pages, 221 KiB  
Article
The Impact of Physical Activity and Screen Time on Motor Creativity in Kindergarteners
by Rafat Ghanamah
Children 2025, 12(2), 116; https://doi.org/10.3390/children12020116 - 22 Jan 2025
Cited by 1 | Viewed by 804
Abstract
Background/Objectives: Motor creativity and physical activity are essential to early childhood development, impacting physical, cognitive, and socio-emotional development. This study investigates the relationships among motor creativity, motor working memory (MSTM), screen time, and physical activity (PA) in kindergarten children, focusing on the mediating [...] Read more.
Background/Objectives: Motor creativity and physical activity are essential to early childhood development, impacting physical, cognitive, and socio-emotional development. This study investigates the relationships among motor creativity, motor working memory (MSTM), screen time, and physical activity (PA) in kindergarten children, focusing on the mediating roles of cognitive functions and screen time. Methods: Data were collected from 124 Arab Israeli kindergarten children through assessments of Thinking Creatively in Action and Movement (TCAM) for motor creativity and the Hand Movement Test for MSTM. Parents reported the children’s screen time and days engaged in moderate-to-vigorous physical activity (MVPA). Results: The results show significant positive associations between motor creativity and both MSTM and PA, underscoring the role of cognitive processes in creative motor expression. Linear regression and mediation analyses showed that MSTM significantly mediates the relationship between PA and motor creativity. Conversely, screen time negatively correlates with PA and motor creativity, serving as a significant mediator that restricts opportunities for physical and creative activities. Conclusions: This study emphasizes the bidirectional relationship between PA and motor creativity, wherein diverse physical activities stimulate creativity, and creative movements encourage active participation. The combined mediating effects of MSTM and screen time highlight the complexity of these relationships, suggesting the need for integrated interventions. The findings inform early childhood education by advocating for strategies that promote physical activity, enhance cognitive functions, and limit excessive screen time, fostering holistic development in young children. Full article
18 pages, 2550 KiB  
Article
A Strategy for Simultaneous Engineering of Interspecies Cross-Reactivity, Thermostability, and Expression of a Bispecific 5T4 x CD3 DART® Molecule for Treatment of Solid Tumors
by Renhua R. Huang, Michael Spliedt, Tom Kaufman, Sergey Gorlatov, Bhaswati Barat, Kalpana Shah, Jeffrey Gill, Kurt Stahl, Jennifer DiChiara, Qian Wang, Jonathan C. Li, Ralph Alderson, Paul A. Moore, Jennifer G. Brown, James Tamura, Xiaoyu Zhang, Ezio Bonvini and Gundo Diedrich
Antibodies 2025, 14(1), 7; https://doi.org/10.3390/antib14010007 - 17 Jan 2025
Viewed by 1168
Abstract
Background: Bispecific antibodies represent a promising class of biologics for cancer treatment. However, their dual specificity and complex structure pose challenges in the engineering process, often resulting in molecules with good functional but poor physicochemical properties. Method: To overcome limitations in the properties [...] Read more.
Background: Bispecific antibodies represent a promising class of biologics for cancer treatment. However, their dual specificity and complex structure pose challenges in the engineering process, often resulting in molecules with good functional but poor physicochemical properties. Method: To overcome limitations in the properties of an anti-5T4 x anti-CD3 (α5T4 x αCD3) DART molecule, a phage-display method was developed, which succeeded in simultaneously engineering cross-reactivity to the cynomolgus 5T4 ortholog, improving thermostability and the elevating expression level. Results: This approach generated multiple DART molecules that exhibited significant improvements in all three properties. The lead DART molecule demonstrated potent in vitro and in vivo anti-tumor activity. Although its clearance in human FcRn-transgenic mice was comparable to that of the parental molecule, faster clearance was observed in cynomolgus monkeys. The lead α5T4 x αCD3 DART molecule displayed no evidence of off-target binding or polyspecificity, suggesting that the increased affinity for the target may account for its accelerated clearance in cynomolgus monkeys. Conclusions: This may reflect target-mediated drug disposition (TMDD), a potential limitation of targeting 5T4, despite its limited expression in healthy tissues. Full article
(This article belongs to the Section Antibody Discovery and Engineering)
Show Figures

Figure 1

Figure 1
<p>DART molecule structure and workflow to improve biophysical properties of 5T4 x CD3 DART molecules. (<b>A</b>). Schematic showing the design and components of the basic DART molecule. The light chain of antibody A (VL<sub>A</sub>) is linked to the heavy chain of antibody B (VH<sub>B</sub>) and expressed as one chain, which pairs with a second chain consisting of the light chain of antibody B (VL<sub>B</sub>) and the heavy chain of antibody A (VH<sub>A</sub>). C-terminal of the VH domain in each chain is a cysteine residue and a charged coil (either K- or E-coil), which stabilize the structure. (<b>B</b>). The structure of an Fc-bearing DART molecule, which consists of the basic DART unit and the CH2 and CH3 of an Fc domain. (<b>C</b>). Physicochemical properties of α5T4wt x αCD3<sup>low</sup> and two variants. Melting temperature T<sub>m</sub>, affinities to human and cyno 5T4 as determined by surface plasmon resonance (SPR), and the titer in supernatants of transiently transfected CHO cells after elution from protein-A resin are shown. (<b>D</b>). Workflow of the experimental design. The basic DART molecules displayed on M13 phage were screened to identify variants with improved properties. Selected variants were further characterized by various bioanalytical, in vitro, and in vivo methods.</p>
Full article ">Figure 2
<p>Design and biopanning of the two mutagenic phage DART libraries. (<b>A</b>). The design and sequence logo of a site-directed mutagenic library (library 1). Kunkel mutagenesis was performed to randomize positions 57–61 in VH-CDR2 and positions 100–102 in VH-CDR3. Sequence logos of the randomized regions in library 1 prior to biopanning are shown. Kabat positions and amino acid residues used for diversifying these positions are listed below them. (<b>B</b>). The α5T4v2 variant (VH and VL) was used as a template for error-prone PCR to create a mutant library with random point mutations (library 2), which are indicated by the arrows. (<b>C</b>). Workflow of the experimental steps from DART library creation, biopanning to ELISA screening.</p>
Full article ">Figure 3
<p>Phage ELISA to screen for variants with improved stability. (<b>A</b>). A schematic of the ELISA with heated phage to screen for stable variants. The antigen coated on the microtiter plate is used to capture the phage particles that are either heated or unheated, followed by detection with anti-M13 antibody conjugated to horse radish peroxidase (HRP). (<b>B</b>). Dot plot of phage ELISA with selected variants from library 1 (directed mutations) plus parent molecule (α5T4v1 x αCD3<sup>low</sup>). Phage supernatants of variants were used directly or were heated at 58 °C for 1 h prior to ELISA. Phage supernatants of α5T4v1 x αCD3<sup>low</sup> were assayed in duplicate to obtain a trendline (green line). The variants above the trendline retained binding better and thus were more stable than the parent molecule. The variant in magenta color is the lead DART molecule, α5T4v3 x αCD3<sup>low</sup>. (<b>C</b>). Equivalent dot plot as in B. for variants selected from library 2 (random mutations). Variants above the green line retained binding better than the parent molecule α5T4v2 x αCD3<sup>low</sup> after being heated at 54 °C for 1 h.</p>
Full article ">Figure 4
<p>Physicochemical properties of selected variants. (<b>A</b>). Affinity measurement by SPR of α5T4wt x αCD3<sup>low</sup> and α5T4v3 x αCD3<sup>low</sup> to human or cyno 5T4. (<b>B</b>). Physicochemical properties of selected variants: affinities to human or cyno 5T4, cyno/human affinity ratio, melting temperature T<sub>m</sub>, number of the mutations in comparison to α5T4wt x αCD3<sup>low</sup>, titer in supernatants of transiently transfected CHO cells, and % monomer after elution from protein-A resin. The three parent DART molecules are listed in yellow rows; the new variants are listed in green rows.</p>
Full article ">Figure 5
<p>In vitro T-cell-mediated tumor cytotoxicity and cytokine secretion of 5T4 x CD3 DART molecules. Lysis of A498 kidney cancer cells (<b>A</b>) or HCT-116 (<b>B</b>) and associated secretion of TNF-α and IFN-γ to evaluate the potency of α5T4v3 x αCD3<sup>low</sup> in comparison to α5T4wt x αCD3<sup>high</sup> and α5T4wt x αCD3<sup>low</sup>. PBMCs were mixed with the tumor cells at a ratio of 10:1 with various concentrations of the DART molecules. After 48 h, the number of live tumor cells was analyzed by flow cytometry, and the cytokine production was measured by ELISA.</p>
Full article ">Figure 6
<p>Anti-tumor activity of α5T4v3 x αCD3<sup>low</sup> in cell-line-derived xenograft models. (<b>A</b>). In vivo studies of α5T4v3 x αCD3<sup>low</sup> in HCT-116 xenograft model. Human PBMCs were injected into NSG/MHCI-/- mice at day 0, followed by injection of tumor cells at day 7. α5T4v3 x αCD3<sup>low</sup> was administered once a week starting at day 7. (<b>B</b>). In vivo studies of α5T4v3 x αCD3<sup>low</sup> in MDA-MB-231 xenograft model.</p>
Full article ">Figure 7
<p>Pharmacokinetic (PK) studies of α5T4wt x αCD3<sup>low</sup> and α5T4v3 x αCD3<sup>low</sup> in human FcRn-transgenic mice and cynomolgus monkeys. (<b>A</b>). PK studies comparing the clearance of α5T4wt x αCD3<sup>low</sup> and α5T4v3 x αCD3<sup>low</sup> in human FcRn transgenic mice. DART molecules were administered intravenously at 5 mg/kg, and blood samples were collected at various timepoints after injection. The plasma concentrations of the DART molecules at each time point were measured by ELISA, and the values shown are the mean concentrations of five mice in each study. (<b>B</b>). PK studies conducted in cynomolgus monkeys to compare the clearance rates of α5T4wt x αCD3<sup>low</sup> and α5T4v3 x αCD3<sup>low</sup>. Two animals were used for each molecule.</p>
Full article ">Figure 8
<p>Evaluating the off-target binding and polyspecificity of 5T4 x CD3 DART variants. (<b>A</b>). Binding of α5T4v3 x αCD3<sup>low</sup> to an array of 6000 membrane proteins expressed in QT6 cells was evaluated by flow cytometry. Membrane proteins with a specific binding signal are highlighted in blue (5T4 and CD3 epsilon). Specific binding is defined as a signal &gt; 3 standard deviations above the mean background value (indicated by the green line). (<b>B</b>). Insulin binding ELISA. The histogram represents the fold change of binding to insulin over the baseline binding without the test article. For α5T4v3 x αCD3<sup>low</sup>, variants with and without YTE mutations in the Fc domain were included in the assays. Lenzilumab and basiliximab are control antibodies with high or low non-specific binding, respectively. The error bar is the standard deviation of two replicate measurements. (<b>C</b>). DNA binding ELISA. Data were processed and summarized as for the insulin ELISA.</p>
Full article ">
13 pages, 3243 KiB  
Article
Genetically Engineered Bacterial Ghosts as Vaccine Candidates Against Klebsiella pneumoniae Infection
by Svetlana V. Dentovskaya, Anastasia S. Vagaiskaya, Alexandra S. Trunyakova, Alena S. Kartseva, Tatiana A. Ivashchenko, Vladimir N. Gerasimov, Mikhail E. Platonov, Victoria V. Firstova and Andrey P. Anisimov
Vaccines 2025, 13(1), 59; https://doi.org/10.3390/vaccines13010059 - 10 Jan 2025
Viewed by 799
Abstract
Background/Objectives Bacterial ghosts (BGs), non-living empty envelopes of bacteria, are produced either through genetic engineering or chemical treatment of bacteria, retaining the shape of their parent cells. BGs are considered vaccine candidates, promising delivery systems, and vaccine adjuvants. The practical use of BGs [...] Read more.
Background/Objectives Bacterial ghosts (BGs), non-living empty envelopes of bacteria, are produced either through genetic engineering or chemical treatment of bacteria, retaining the shape of their parent cells. BGs are considered vaccine candidates, promising delivery systems, and vaccine adjuvants. The practical use of BGs in vaccine development for humans is limited because of concerns about the preservation of viable bacteria in BGs. Methods: To increase the efficiency of Klebsiella pneumoniae BG formation and, accordingly, to ensure maximum killing of bacteria, we exploited previously designed plasmids with the lysis gene E from bacteriophage φX174 or with holin–endolysin systems of λ or L-413C phages. Previously, this kit made it possible to generate bacterial cells of Yersinia pestis with varying degrees of hydrolysis and variable protective activity. Results: In the current study, we showed that co-expression of the holin and endolysin genes from the L-413C phage elicited more rapid and efficient K. pneumoniae lysis than lysis mediated by only single gene E or the low functioning holin–endolysin system of λ phage. The introduction of alternative lysing factors into K. pneumoniae cells instead of the E protein leads to the loss of the murein skeleton. The resulting frameless cell envelops are more reminiscent of bacterial sacs or bacterial skins than BGs. Although such structures are less naive than classical bacterial ghosts, they provide effective protection against infection by a hypervirulent strain of K. pneumoniae and can be recommended as candidate vaccines. For our vaccine candidate generated using the O1:K2 hypervirulent K. pneumoniae strain, both safety and immunogenicity aspects were evaluated. Humoral and cellular immune responses were significantly increased in mice that were intraperitoneally immunized compared with subcutaneously vaccinated animals (p < 0.05). Conclusions: Therefore, this study presents novel perspectives for future research on K. pneumoniae ghost vaccines. Full article
(This article belongs to the Section Vaccines against Infectious Diseases)
Show Figures

Figure 1

Figure 1
<p>Preparation of <span class="html-italic">K. pneumoniae</span> KPI1627 BGs. Growth and lysis were monitored by measuring OD<sub>550</sub> (<b>A</b>) and the determination of the number of CFU (<b>B</b>). The data are presented as the mean ± s.d. of three samples.</p>
Full article ">Figure 2
<p>Transmission electron micrographs of <span class="html-italic">K. pneumoniae</span> strains: (<b>A</b>) KPI1627, (<b>B</b>) KPI1627/pEYR’-E, (<b>C</b>) KPI1627/pEYR’-S-R-Rz, (<b>D</b>) KPI1627/pEYR’-E-S-R-Rz, (<b>E</b>) KPI1627/pEYR’-Y-K, (<b>F</b>) KPI1627/pEYR’-E-Y-K. The bar represents 1 μm (<b>A</b>,<b>C</b>–<b>F</b>) or 500 nm (<b>B</b>).</p>
Full article ">Figure 3
<p>Antibody response in sera of mice immunized s.c. and i.p. with KPI-Y-K and PBS. #—<span class="html-italic">p</span> &gt; 0.05; *—<span class="html-italic">p</span> &lt; 0.05; **—<span class="html-italic">p</span> &lt; 0.005; ****—<span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 4
<p>Specific IFN-γ, IL-6, and TNF-α levels of splenic lymphocytes from immunized mice. * <span class="html-italic">p</span> &lt; 0.05 vs. PBS group.</p>
Full article ">Figure 5
<p>The expression levels of CD69 on CD3<sup>+</sup>CD4<sup>+</sup>, CD3<sup>+</sup>CD8<sup>+</sup>, and CD19<sup>+</sup> cell subsets of splenic lymphocytes from immunized mice. The splenic lymphocytes of mice were separated 28 days after the first immunization, and corresponding BGs were used as immunogens. Following a 48-h incubation period, lymphocytes were harvested and subjected to flow cytometry analysis. ** <span class="html-italic">p</span> &lt; 0.005 vs. PBS group. Graphs and histograms show the distribution of CD69 expression in the lymphocyte subsets.</p>
Full article ">Figure 6
<p>Protection of <span class="html-italic">KP</span>-BGs against a lethal challenge with the wild-type <span class="html-italic">K. pneumoniae</span> KPI1627 strain. Mice were subjected to i.p. and s.c. immunization with KPI-YK BGs at day 0 and boosted twice at 10 and 20 days. Ten days after the last immunization, 10 mice from each group were challenged i.p. with 10<sup>4</sup> CFUs of <span class="html-italic">K. pneumoniae</span> KPI1627 (5000 LD<sub>50</sub>). **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">
16 pages, 924 KiB  
Article
Unpacking the Mood States of Children and Youth in Saskatchewan, Canada, in the Context of the COVID-19 Pandemic: Insights from the “See Us, Hear Us 2.0” Study
by Nahin Shakurun, Tamara Hinz, Daniel A. Adeyinka and Nazeem Muhajarine
Children 2025, 12(1), 79; https://doi.org/10.3390/children12010079 - 10 Jan 2025
Cited by 1 | Viewed by 688
Abstract
Background/Objectives: The COVID-19 pandemic created a growing need for insights into the mental health of children and youth and their use of coping mechanisms during this period. We assessed mood symptoms and related factors among children and youth in Saskatchewan. We examined if [...] Read more.
Background/Objectives: The COVID-19 pandemic created a growing need for insights into the mental health of children and youth and their use of coping mechanisms during this period. We assessed mood symptoms and related factors among children and youth in Saskatchewan. We examined if coping abilities mediated the relationship between risk factors and mood states. Methods: “See Us, Hear Us 2.0”, a cross-sectional study of 563 child–parent dyads, provided the data. The dependent variable, current mood state, was measured by the CoRonavIruS health Impact Survey (CRISIS) scale. Independent variables included sociodemographics, behaviors, household conditions, and coping ability. Multiple linear regression and mediation analyses were conducted, ensuring sample representativeness with sampling weights and addressing missing data through multiple imputations. Results: The participants reported mood symptoms (“moderate” to “extreme”) ranging from 23% to 38% on the CRISIS scale. Factors such as older children, hybrid learning, disrupted activities, and increased screen time worsened moods. The ethnic minority groups (BIPOC) living in mid-sized cities/towns experienced more negative moods compared to Whites residing in cities. Coping ability mediated the relationship between extracurricular activities and mood states. Conclusions: Our results underscore the importance of tailored interventions, recognizing the diverse needs of specific age groups, gender identities, and ethnicities and addressing the adverse effects of the pandemic-related disruptions on the mental health and well-being of school children in Saskatchewan. Our study also suggests prioritizing the diverse needs of children and youth during the planning and implementation of mental health services in the province. Full article
(This article belongs to the Special Issue Child and Adolescent Psychiatry: A Post-COVID Era?)
Show Figures

Figure 1

Figure 1
<p>Prevalence of mood symptoms (from “moderate” to “extreme” in the CRISIS scale) in children and youth (8–18 years) in Saskatchewan.</p>
Full article ">Figure 2
<p>(<b>a</b>) Location of residence modifies the effect of ethnicity in predicting mood states in children and youth in Saskatchewan. (<b>b</b>) Immigration status modifies the effect of ethnicity in predicting negative mood states in children and youth in Saskatchewan.</p>
Full article ">Figure 3
<p>The mediational effect of coping ability of children and youth in the relationship between extracurricular activities and the current mood states of the respondents.</p>
Full article ">
14 pages, 3083 KiB  
Article
Effects of 1H-1,2,3-Triazole Derivatives of 3-O-Acetyl-11-Keto-Beta-Boswellic Acid from Boswellia sacra Resin on T-Cell Proliferation and Activation
by Abdo Meyiah, Satya Kumar Avula, Ahmed Al-Harrasi and Eyad Elkord
Pharmaceuticals 2024, 17(12), 1650; https://doi.org/10.3390/ph17121650 - 8 Dec 2024
Viewed by 812
Abstract
Background: 3-O-acetyl-11-keto-β-boswellic acid (β-AKBA), a triterpene natural product, is one of the main natural products of Boswellia sacra resin (BSR) and has reported biological and immunomodulatory effects. 1H-1,2,3-triazole derivatives of β-AKBA (named 6a [...] Read more.
Background: 3-O-acetyl-11-keto-β-boswellic acid (β-AKBA), a triterpene natural product, is one of the main natural products of Boswellia sacra resin (BSR) and has reported biological and immunomodulatory effects. 1H-1,2,3-triazole derivatives of β-AKBA (named 6a6d) were synthesized from β-AKBA. The 1H-1,2,3-triazole compounds are also known to have a wide range of biological and pharmacological properties as demonstrated by in vitro and in vivo studies. This study aimed to investigate the effects of these 1H-1,2,3-triazole derivatives of β-AKBA on human T-cell proliferation and activation. Methods: PBMCs isolated from healthy donors were activated by anti-CD3/CD28 monoclonal antibodies in the presence of β-AKBA (1) or 1H-1,2,3-triazole derivatives of β-AKBA or DMSO controls. Results: We found that similar to the parent compound β-AKBA (1), derivatives 6a, 6b, and 6d significantly inhibited T-cell expansion/proliferation and reduced the levels of CD25 activation marker on CD4+ and CD8+ T cells without exerting significant cytotoxic effects on T-cell viability at a concentration of 25 µM. However, compound 6c further inhibited T-cell expansion/proliferation and CD25 expression, but had a significant cytotoxic effect on cell viability at similar concentrations of 25 µM. Conclusions: These findings demonstrate the immunoinhibitory effects of β-AKBA (1) and its corresponding triazole derivatives on T-cell proliferation and activation, highlighting the promising therapeutic potential of these compounds in T-cell-mediated diseases. Full article
(This article belongs to the Section Medicinal Chemistry)
Show Figures

Figure 1

Figure 1
<p>Peripheral blood mononuclear cells (PBMCs) were treated with the compounds or DMSO as control. Representative photomicrographs of T lymphocytes stimulated with anti-human CD3/CD28 antibodies and treated with two concentrations (12.5 and 25 µM) of <span class="html-italic">β</span>-AKBA <b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>6a</b>, <b>6b</b>, <b>6c</b>, or <b>6d</b> derivatives as observed by microscopy after three days of stimulation.</p>
Full article ">Figure 2
<p>The effect of <span class="html-italic">β</span>-AKBA and derivative compounds at a concentration of 25 µM on T-cell viability after three days of stimulation was determined by FVD-450 dye and flow cytometry. Representative flow cytometric plots are shown in (<b>A</b>); gates indicate the percentage of viable cells. The overall viability bar plots for all experiments performed (n = 7) are shown in (<b>B</b>). Compound <b>6c</b> significantly reduced T-cell viability compared with DMSO. ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 3
<p>The effect of <span class="html-italic">β</span>-AKBA and derivative compounds at a 25 µM concentration on T-cell proliferation was determined by CFSE loss. Representative flow cytometric plots are shown in (<b>A</b>); gates indicate the percentage of proliferating cells The overall cell proliferation bar plots for all experiments performed (n = 8) are shown in (<b>B</b>). Compared with DMSO, the other compounds (<b>1</b>, <b>6a</b>, <b>6b</b>, <b>6c</b>, and <b>6d</b>) significantly reduced T-cell proliferation. Additionally, using an unpaired <span class="html-italic">t</span>-test, only compound <b>6c</b> significantly reduced T-cell proliferation compared to <span class="html-italic">β</span>-AKBA (<span class="html-italic">t</span>-test, # <span class="html-italic">p</span> &lt; 0.05). * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; **** <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 4
<p>The effect of <span class="html-italic">β</span>-AKBA and derivative compounds at a concentration of 25 µM on the expression of CD25 in CD4<sup>+</sup> T cells. Activated T cells were stained with mAbs and evaluated by flow cytometry. Representative flow cytometric plots showing the gating and percentage of CD25<sup>+</sup> in CD4<sup>+</sup> T cells in the presence of <span class="html-italic">β</span>-AKBA and derivative compounds (<b>A</b>). The overall percentages of CD4<sup>+</sup>CD25<sup>+</sup> T-cell bar plots for all experiments performed (n = 8) are shown in (<b>B</b>). Compounds <b>1</b>, <b>6a</b>, and <b>6c</b> significantly reduced the CD25 T-cell activation marker on CD4<sup>+</sup> T cells, compared with DMSO. * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 5
<p>The effect of <span class="html-italic">β</span>-AKBA and derivative compounds at a concentration of 25 µM on the expression of CD25<sup>+</sup> in CD8<sup>+</sup> T cells. Activated T cells were stained with mAbs and evaluated by flow cytometry. Representative flow cytometric plots showing the gating and percentage of CD25<sup>+</sup> in CD8<sup>+</sup> T cells in the presence of <span class="html-italic">β</span>-AKBA and derivative compounds (<b>A</b>). The overall percentages of CD8<sup>+</sup>CD25<sup>+</sup> T-cell bar plots for all experiments performed (n = 8) are shown in (<b>B</b>). Compounds <b>1</b>, <b>6a</b>, <b>6b</b>, <b>6c</b>, and <b>6d</b> significantly reduced the CD25 T-cell activation marker on CD8<sup>+</sup> T cells, compared with DMSO. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Scheme 1
<p>Gram-scale production of <span class="html-italic">β</span>-AKBA (<b>1</b>) isolated from BSR.</p>
Full article ">Scheme 2
<p>Synthesis of 1<span class="html-italic">H</span>-1,2,3-triazole derivatives of <span class="html-italic">β</span>-AKBA (<b>6a</b>–<b>6d</b>).</p>
Full article ">
15 pages, 2522 KiB  
Article
Synthesis, Analytical Characterization, and Human CB1 Receptor Binding Studies of the Chloroindole Analogues of the Synthetic Cannabinoid MDMB-CHMICA
by Sascha Münster-Müller, Steven Hansen, Tobias Lucas, Arianna Giorgetti, Lukas Mogler, Svenja Fischmann, Folker Westphal, Volker Auwärter, Michael Pütz and Till Opatz
Biomolecules 2024, 14(11), 1414; https://doi.org/10.3390/biom14111414 - 6 Nov 2024
Viewed by 1291
Abstract
Synthetic cannabinoids (SCs) are one of the largest groups of new psychoactive substances (NPSs). However, the relationship between their chemical structure and the affinity to human CB1 receptors (hCB1), which mediates their psychotropic activity, is not well understood. Herein, the [...] Read more.
Synthetic cannabinoids (SCs) are one of the largest groups of new psychoactive substances (NPSs). However, the relationship between their chemical structure and the affinity to human CB1 receptors (hCB1), which mediates their psychotropic activity, is not well understood. Herein, the synthesis of the 2-, 4-, 5-, 6- and 7-chloroindole analogues of the synthetic cannabimimetic MDMB-CHMICA, along with their analytical characterization via ultraviolet–visible (UV/VIS), infrared (IR), nuclear magnetic resonance (NMR) spectroscopy, and mass spectrometry, is described. Furthermore, all five derivatives of MDMB-CHMICA were analyzed for their hCB1 binding affinities. Chlorination at position 4 and 5 of the indole core reduced the binding affinity compared to MDMB-CHMICA, while the test compounds chlorinated in positions 2, 6, and 7 largely retained their binding affinities relative to the non-chlorinated parent compound. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Structural formula for MDMB-CHMICA and its five chloroindole derivatives.</p>
Full article ">Figure 2
<p>Expansion of the aromatic region of the <sup>1</sup>H-NMR spectra (400 MHz, DMSO-d<sub>6</sub>) for the five chloroindole isomers of MDMB-CHMICA. The numbers indicate the positions on the indole skeleton of the protons causing the signals. The unlabeled doublet signals are NH resonances.</p>
Full article ">Figure 3
<p>GC-EI-MS spectra of 2-Cl-, 6-Cl-, and 7-Cl-MDMB-CHMICA.</p>
Full article ">Figure 4
<p>Stacked GC-sIR spectra of the five chloroindole isomers of MDMB-CHMICA.</p>
Full article ">Figure 5
<p>UV/VIS spectra for the five chloroindole isomers of MDMB-CHMICA.</p>
Full article ">Figure 6
<p>Concentration–displacement curves at the hCB<sub>1</sub> receptor as obtained with the [<sup>3</sup>H]CP-55,940 mediated in vitro competitive binding affinity assay with the tested compounds. Data are shown as mean receptor affinity ± SEM, and experiments were performed in triplicate. ns = non significant difference; **** = significant difference with <span class="html-italic">p</span> = 0.0001.</p>
Full article ">Scheme 1
<p>Synthesis of 2-chloroindole-3-carbaldehyde from oxindole. Reagents and conditions: (a) POCl<sub>3</sub>, DMF, DCM, H<sub>2</sub>O.</p>
Full article ">Scheme 2
<p>Synthesis of the 2-chloro- and 5-chloroindole analogue of MDMB-CHMICA. Reagents and conditions: (a) (i) NaH (60%), DMF; (ii) (bromomethyl)cyclohexane, DMF; (b) KMnO<sub>4</sub>, acetone; (c) (i) Hünig’s base, HATU, DMF; (ii) DMF, TLME. The numbers indicate the positions on the indole skeleton.</p>
Full article ">Scheme 3
<p>Synthesis of the 4-chloro, 6-chloro and 7-chloro indole analogue of MDMB-CHMICA. Reagents and conditions: (a) (i) NaH (60% in mineral oil), (bromomethyl)cyclohexane, DMF; (ii) (CF<sub>3</sub>CO)<sub>2</sub>O, DMF; (b) KOH, MeOH, PhMe; (c) (i) Hünig’s base, HATU, DMF; (ii) DMF, TLME. The numbers indicate the positions on the indole skeleton.</p>
Full article ">
15 pages, 3130 KiB  
Article
Role of Peroxisome Proliferator-Activated Receptor α-Dependent Mitochondrial Metabolism in Ovarian Cancer Stem Cells
by Seo Yul Lee, Min Joo Shin, Seong Min Choi, Dae Kyoung Kim, Mee Gyeon Choi, Jun Se Kim, Dong Soo Suh, Jae Ho Kim and Seong Jang Kim
Int. J. Mol. Sci. 2024, 25(21), 11760; https://doi.org/10.3390/ijms252111760 - 1 Nov 2024
Viewed by 1160
Abstract
Peroxisome proliferator-activated receptors (PPARs), including PPAR-α, PPAR-β/δ, and PPAR-γ, are involved in various cellular responses, including metabolism and cell proliferation. Increasing evidence suggests that PPARs are closely associated with tumorigenesis and metastasis. However, the exact role of PPARs in energy metabolism and cancer [...] Read more.
Peroxisome proliferator-activated receptors (PPARs), including PPAR-α, PPAR-β/δ, and PPAR-γ, are involved in various cellular responses, including metabolism and cell proliferation. Increasing evidence suggests that PPARs are closely associated with tumorigenesis and metastasis. However, the exact role of PPARs in energy metabolism and cancer stem cell (CSC) proliferation remains unclear. This study investigated the role of PPARs in energy metabolism and tumorigenesis in ovarian CSCs. The expression of PPARs and fatty acid consumption as an energy source increased in spheroids derived from A2780 ovarian cancer cells (A2780-SP) compared with their parental cells. GW6471, a PPARα inhibitor, induced apoptosis in A2780-SP. PPARα silencing mediated by small hairpin RNA reduced A2780-SP cell proliferation. Treatment with GW6471 significantly inhibited the respiratory oxygen consumption of A2780-SP cells, with reduced dependency on fatty acids, glucose, and glutamine. In a xenograft tumor transplantation mouse model, intraperitoneal injection of GW6471 inhibited in vivo tumor growth of A2780-SP cells. These results suggest that PPARα plays a vital role in regulating the proliferation and energy metabolism of CSCs by altering mitochondrial activity and that it offers a promising therapeutic target to eradicate CSCs. Full article
(This article belongs to the Section Molecular Pharmacology)
Show Figures

Figure 1

Figure 1
<p>Role of PPARs in energy metabolism of ovarian CSCs. (<b>A</b>) The dependence of each carbon source (fuel) dependency was calculated from the oxygen consumption rates measured by the Seahorse analyzer using the Mito Fuel Flex test kit. Cells were treated with 0.1% DMSO or 5 μM GW6471 for 24 h before performing the Mito Fuel Flex test. (<b>B</b>) The mRNA expression levels of PPARs in A2780 (non-CSC) and A2780-SP (CSC) cells. (<b>C</b>) PPAR transcriptional activity was measured using Dual-Luciferase Reporter assay. Cells were transfected with luciferase plasmid vectors 48 h before measuring luciferase signal activity. Data are presented as mean ± SEM. ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001 (<span class="html-italic">n</span> = 3 for each group). PPAR, peroxisome proliferator-activated receptor; DMSO, dimethyl sulfoxide; CSC, cancer stem cell; mRNA, messenger ribonucleic acid; SEM, standard error of the mean.</p>
Full article ">Figure 2
<p>Effects of PPAR antagonists on cell viability of ovarian CSCs. (<b>A</b>) Cell viability was determined by MTT assay. CSCs were treated with the indicated concentrations of antagonists (GW6471, GW9662, GSK0660) for 48 h. (<b>B</b>) Representative images of spheroid formation assay of CSCs in the presence or absence of GW6471. Scale bar, 200 μm. (<b>C</b>) Quantification of spheroid number in spheroid formation assay. The number of spheroids with a diameter &gt; 100 μm was counted. Data are presented as mean ± SEM. *** <span class="html-italic">p</span> &lt; 0.001 (<span class="html-italic">n</span> = 3 for each group). (<b>D</b>) Representative immunocytochemistry images for detection of cleaved caspase-3. CSCs were treated with 0.1% DMSO (mock) or 10 μM GW6471 for 48 h before staining. Scale bar, 100 μm. PPAR, peroxisome proliferator-activated receptor; CSC, cancer stem cell; MTT, 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide; DMSO, dimethyl sulfoxide; SEM, standard error of the mean.</p>
Full article ">Figure 3
<p>Effects of PPARα knockdown on cell proliferation and spheroid-forming abilities of CSCs. (<b>A</b>) Relative mRNA expression of PPARα in CSCs transduced with lentiviruses bearing sh-PPARα or sh-control was measured by qRT-PCR. (<b>B</b>) Cell proliferation assessed by WST assay at indicated time points. (<b>C</b>) Representative images of spheroid formation in CSCs transduced with lentiviruses bearing sh-PPARα or sh-control. Scale bar, 300 μm (<b>D</b>) Quantification of spheroid numbers in spheroid formation assay. The number of spheroids &gt; 150 μm in diameter. Data are presented as mean ± SEM. ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001 (<span class="html-italic">n</span> = 3 for each group). PPAR: peroxisome proliferator-activated receptor; CSC: cancer stem cell; mRNA: messenger ribonucleic acid; sh: small hairpin; qRT-PCR: quantitative reverse transcription–polymerase chain reaction; WST: water-soluble tetrazolium salt; SEM: standard error of the mean.</p>
Full article ">Figure 4
<p>Effects of GW6471 on the mitochondrial metabolism of ovarian CSCs. (<b>A</b>) Oxygen consumption rates of the mock and GW6471-treated groups were measured with a Seahorse analyzer using the Mito Stress test kit. Oligo: oligomycin; FCCP: carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone; R/A: rotenone and antimycin A. (<b>B</b>) Mitochondrial metabolic parameters were calculated from the Mito Stress test results. Basal: basal respiration; maximal: maximal respiration; spare: spare respiratory capacity; non-mito: nonmitochondrial respiration. (<b>C</b>) Dependence on each carbon source (fuel) was calculated from oxygen consumption rates measured by a Seahorse analyzer using the Mito Fuel Flex test kit. CSCs were treated with 0.1% DMSO or 5 μM GW6471 for 24 h before performing the Mito Stress Test or Mito Fuel Flex test. Data are presented as mean ± SEM. *** <span class="html-italic">p</span> &lt; 0.001 (<span class="html-italic">n</span> = 3 for each group). CSC: cancer stem cell; DMSO: dimethyl sulfoxide; SEM: standard error of the mean.</p>
Full article ">Figure 5
<p>Effects of GW6471 on in vivo tumor growth of ovarian CSCs. (<b>A</b>) Experimental overview of ovarian cancer xenotransplantation model. Treatment with PBS or 20 μM GW6471 was started on day 22 after cell injection and continued twice a week until day 40. (<b>B</b>) Representative images of mice and resected tumors at day 43. (<b>C</b>) Tumor weight measured after resection on day 43. (<b>D</b>,<b>E</b>) Tumor volume (<b>D</b>) and mouse body weight (<b>E</b>) were measured twice a week from day 22 to day 43. Data are presented as mean ± SEM. * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01 (<span class="html-italic">n</span> = 3 for each group). CSC: cancer stem cell; PBS: phosphate-buffered saline; SEM: standard error of the mean.</p>
Full article ">Figure 6
<p>Role of PPARs in the prognosis of patients with ovarian cancer. Kaplan–Meier survival curves for overall survival and disease-free survival stratified by the expression level of PPAR subtypes (<span class="html-italic">PPARA</span>, <span class="html-italic">PPARG</span>, <span class="html-italic">PPARD</span>). (<b>A</b>,<b>C</b>,<b>E</b>) Overall survival of patients with low (blue line) or high (red line) expression of <span class="html-italic">PPARA</span>, <span class="html-italic">PPARG</span>, or <span class="html-italic">PPARD</span>, respectively. (<b>B</b>,<b>D</b>,<b>F</b>) Disease-free survival for patients with low (blue line) or high (red line) expression of <span class="html-italic">PPARA</span>, <span class="html-italic">PPARG</span>, or <span class="html-italic">PPARD</span>, respectively. * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001. PPAR: peroxisome proliferator-activated receptor; n: number of patients in each group; HR: hazard ratio; 95% CI: 95% confidence interval.</p>
Full article ">
15 pages, 1059 KiB  
Article
LEGO®-Based Therapy in School Settings for Social Behavior Stimulation in Children with Autism Spectrum Disorder: Comparing Peer-Mediated and Expert Intervention
by Luciana Oliveira Angelis, Fernanda Tebexreni Orsati and Maria Cristina Triguero Veloz Teixeira
Brain Sci. 2024, 14(11), 1114; https://doi.org/10.3390/brainsci14111114 - 1 Nov 2024
Viewed by 2267
Abstract
Background: LEGO®-based therapy is a social development protocol that uses LEGO® activities to support the development of a wide range of interaction skills, enhancing prosocial behaviors and mitigating the challenges associated with mental health difficulties and behavioral issues commonly observed [...] Read more.
Background: LEGO®-based therapy is a social development protocol that uses LEGO® activities to support the development of a wide range of interaction skills, enhancing prosocial behaviors and mitigating the challenges associated with mental health difficulties and behavioral issues commonly observed in children with autism spectrum disorder (ASD). Objectives: This study aimed to explore the effects of LEGO®-based therapy on the social behavior and mental health of children with ASD, comparing stimulation mediated by expert and stimulation mediated by non-autistic peers. This study was approved by the Ethical Committee at Mackenzie Presbyterian University, ensuring adherence to ethical standards throughout the research process. Methods: This study involved 18 children with ASD, levels 1 or 2, with an intelligence quotient (IQ) above 70, and three typically developing peers, intelligence quotient (IQ) above 80, aged between 5 and 8 years old, of both sexes. Participants were randomized into three groups for stimulation (stimulation mediated by expert, by a non-autistic peer and control group). The measures were the Wechsler Abbreviated Scale of Intelligence, the Strengths and Difficulties Questionnaire (parent and teacher versions), the Inventory of Difficulties in Executive Functions, Regulation, and Aversion to Delay—Child Version, the Developmental Coordination Disorder Questionnaire, the Autism Behavior Checklist, and the Autistic Behavior Inventory. Results: After 14 sessions of 45 min in school settings, the participants of both groups (mediated by experts and non-autistic children) showed significant gains on social behavior. A statistically significant difference was observed between baseline sessions and probes (χ2 (5) = 25.905, p < 0.001). These gains were maintained in both follow-up points, 30 and 90 days after the completion of the stimulation sessions. Additionally, maladaptive behavior showed a significant decline when compared pre- and post-intervention. These improvements were sustained during follow-up assessments at 30 and 90 days. Conclusions: The results suggest that a structured intervention combined with peer-mediated stimulation may be an effective method for promoting adaptive and prosocial behaviors in children with ASD. Full article
(This article belongs to the Special Issue Exploring the Mental Health of People with Autism)
Show Figures

Figure 1

Figure 1
<p>Stimulation setting created by the first author.</p>
Full article ">Figure 2
<p>Comparison of social behaviors by group at each time point.</p>
Full article ">Figure 3
<p>Index of satisfaction among the participants with the intervention.</p>
Full article ">
22 pages, 1869 KiB  
Review
Molecular and Cellular Effects of Microplastics and Nanoplastics: Focus on Inflammation and Senescence
by Faiza Mahmud, Drishty B. Sarker, Jonathan A. Jocelyn and Qing-Xiang Amy Sang
Cells 2024, 13(21), 1788; https://doi.org/10.3390/cells13211788 - 29 Oct 2024
Cited by 9 | Viewed by 5825
Abstract
Microplastics and nanoplastics (MNPs) are ubiquitous environmental contaminants. Their prevalence, persistence, and increasing industrial production have led to questions about their long-term impact on human and animal health. This narrative review describes the effects of MNPs on oxidative stress, inflammation, and aging. Exposure [...] Read more.
Microplastics and nanoplastics (MNPs) are ubiquitous environmental contaminants. Their prevalence, persistence, and increasing industrial production have led to questions about their long-term impact on human and animal health. This narrative review describes the effects of MNPs on oxidative stress, inflammation, and aging. Exposure to MNPs leads to increased production of reactive oxygen species (ROS) across multiple experimental models, including cell lines, organoids, and animal systems. ROS can cause damage to cellular macromolecules such as DNA, proteins, and lipids. Direct interaction between MNPs and immune cells or an indirect result of oxidative stress-mediated cellular damage may lead to increased production of pro-inflammatory cytokines throughout different MNP-exposure conditions. This inflammatory response is a common feature in the pathogenesis of neurodegenerative, cardiovascular, and other age-related diseases. MNPs also act as cell senescence inducers by promoting mitochondrial dysfunction, impairing autophagy, and activating DNA damage responses, exacerbating cellular aging altogether. Increased senescence of reproductive cells and transfer of MNPs/induced damages from parents to offspring in animals further corroborates the transgenerational health risks of the tiny particles. This review aims to provoke a deeper investigation into the notorious effects these pervasive particles may have on human well-being and longevity. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Micro- and nanoplastic (MNP) weathering process, cellular uptake, and consequent oxidative stress in cells. Plastic particles undergo aging through UV radiation and photo- and thermal oxidation, leading to structural changes and chemical alterations on the surface of the particles. When transported into humans and animals, these microscopic particles are distributed across systems and ultimately taken up by various cell types. MNP internalization is accompanied by the generation of free radicals inside cells, meaning elevated reactive oxygen species (ROS) levels and ensuing oxidative stress. The presence of MNPs within cells and consequent ROS overload damage organelles and impair their functions. At molecular levels, lipid and protein oxidation debilitates their structure and function, while oxidative DNA damage may give rise to mutations.</p>
Full article ">Figure 2
<p>Molecular and cellular events leading to inflammation and senescence upon MNP exposure. Orange cube: key molecular consequences; orange sphere: detailed expression of relevant biomarkers; green cube: key cellular consequences; green sphere: detailed expression of relevant biomarkers; solid lines indicate the interconnectedness of biomarkers and key events; double-sided arrow: evidence suggests that key events are linked; dashed lines suggest that the key event may, in part, be a consequence of another key event; asterisk (*): indicates that IL-6 expression is downregulated in certain contexts due to microplastic exposure.</p>
Full article ">Figure 3
<p>MNP exposure elicits the molecular hallmarks of aging in human and animal cells. Mitochondrial dysfunction (in the forms of excessive ROS generation, loss of membrane potential, and mitochondrial DNA leakage) and ROS-mediated damages such as impaired autophagy, loss of proteostasis, DNA damage, and chromatin modifications trigger senescence in cells. Long-term senescence is detrimental to normal tissue function and ensues aging-related disease manifestations.</p>
Full article ">
9 pages, 441 KiB  
Article
The Relationship Between Parental Academic Achievement Pressure, Physical Activity, Self-Esteem, and Body Image Among South Korean Adolescents
by Gun-Soo Han and Jae-Ahm Park
Adolescents 2024, 4(4), 484-492; https://doi.org/10.3390/adolescents4040034 - 28 Oct 2024
Viewed by 1543
Abstract
The purpose of this study is to analyze the effects of parental academic achievement pressure and physical activity on body image mediated by self-esteem. By examining a total of 1328 South Korean adolescents, this study yielded the following results. First, parental academic achievement [...] Read more.
The purpose of this study is to analyze the effects of parental academic achievement pressure and physical activity on body image mediated by self-esteem. By examining a total of 1328 South Korean adolescents, this study yielded the following results. First, parental academic achievement pressure negatively affects self-esteem directly. Second, physical activity positively affects self-esteem directly. Third, self-esteem positively influences body image directly. Fourth, parental academic achievement pressure has a negative indirect effect on body image through the mediation of self-esteem. Fifth, physical activity has a positive indirect effect on body image through the mediation of self-esteem. These findings underscore the importance of appropriate physical activity, especially for adolescents under significant academic pressure. Physical activity can directly enhance self-esteem, which in turn improves body image. This study highlights the role of physical activity in mitigating the negative impact of parental academic achievement pressure on body image through self-esteem. Full article
Show Figures

Figure 1

Figure 1
<p>The proposed research model. Solid lines indicate a direct effect, while dotted lines represent an indirect effect.</p>
Full article ">
16 pages, 3522 KiB  
Article
RNAi Knockdown of EHMT2 in Maternal Expression of Prader–Willi Syndrome Genes
by Violeta Zaric, Hye Ri Kang, Volodymyr Rybalchenko, Jeffrey M. Zigman, Steven J. Gray and Ryan K. Butler
Genes 2024, 15(11), 1366; https://doi.org/10.3390/genes15111366 - 24 Oct 2024
Viewed by 1179
Abstract
Background/objectives: Euchromatic histone lysine methyltransferase 2 (EHMT2, also known as G9a) is a mammalian histone methyltransferase that catalyzes the dimethylation of histone 3 lysine 9 (H3K9). On human chromosome 15, the parental-specific expression of Prader–Willi Syndrome (PWS)-related genes, such as SNRPN and SNORD116 [...] Read more.
Background/objectives: Euchromatic histone lysine methyltransferase 2 (EHMT2, also known as G9a) is a mammalian histone methyltransferase that catalyzes the dimethylation of histone 3 lysine 9 (H3K9). On human chromosome 15, the parental-specific expression of Prader–Willi Syndrome (PWS)-related genes, such as SNRPN and SNORD116, are regulated through the genetic imprinting of the PWS imprinting center (PWS-IC). On the paternal allele, PWS genes are expressed whereas the epigenetic maternal silencing of PWS genes is controlled by the EHMT2-mediated methylation of H3K9 in PWS-IC. Here, we measured the effects of RNA interference of EHMT2 on the maternal expression of genes deficient in PWS in mouse model and patient iPSC-derived cells. Methods: We used small interfering RNA (siRNA) oligonucleotides and lentiviral short harpin RNA (shRNA) to reduce Ehtm2/EHMT2 expression in mouse Snord116 deletion primary neurons, PWS patient-derived induced pluripotent stem cell (iPSC) line and PWS iPSC-derived neurons. We then measured the expression of transcript or protein (if relevant) of PWS genes normally silenced on the maternal allele. Results: With an approximate reduction of 90% in EHMT2 mRNA and more than 80% of the EHMT2 protein, we demonstrated close to a 2-fold increase in the expression of maternal transcripts for SNRPN and SNORD116 in PWS iPSCs treated with siEHMT2 compared to PWS iPSC siControl. A similar increase in SNORD116 and SNRPN RNA expression was observed in PWS iPSC-derived neurons treated with shEHMT2. Conclusions: RNAi reduction in EHMT2 activates maternally silenced PWS genes. Further studies are needed to determine whether the increase is therapeutically relevant. This study confirms the role of EHMT2 in the epigenetic regulation of PWS genes. Full article
(This article belongs to the Section Human Genomics and Genetic Diseases)
Show Figures

Figure 1

Figure 1
<p>Efficacy of <span class="html-italic">EHMT2</span> transcript reduction with specific siRNAs in human UPD patient-derived iPSCs. (<b>a</b>). Gene expression of <span class="html-italic">EHMT2</span> in PWS UPD iPSCs following transfection with control siRNAs (UNC) or specific siRNAs targeting <span class="html-italic">EHMT2</span>. A significant reduction in EHMT2 was observed with all the siRNA candidates relative to the control; (<b>b</b>) quantification of the EHMT2 protein in UPD iPSCs treated with siRNA targeting EHMT2 and compared to treated cells with the control siRNA UNC; (<b>c</b>) representative image of EHMT2 protein from UPD iPSCs treated with siRNA candidates analyzed by Western blotting; (<b>d</b>) gene expression of <span class="html-italic">SNRPN</span> and (<b>e</b>) gene expression of <span class="html-italic">SNORD116</span> in PWS UPD iPSCs following transfection with control siRNAs (UNC) or specific siRNAs targeting <span class="html-italic">EHMT2</span>. <span class="html-italic">EIF4A2</span> was used as a control. Student’s <span class="html-italic">t</span> test: *, <span class="html-italic">p</span> &lt; 0.05; **, <span class="html-italic">p</span> &lt; 0.01; ***, <span class="html-italic">p</span> &lt; 0.001; ****, <span class="html-italic">p</span> &lt; 0.0001; data represent means ± S.E.M (N = 3–4).</p>
Full article ">Figure 2
<p>Efficacy of <span class="html-italic">Ehmt2</span> transcript reduction with specific siRNAs in mouse primary neurons. (<b>a</b>) Gene expression of <span class="html-italic">Ehmt2</span> in primary neurons from <span class="html-italic">Snord116<sup>p−/m+</sup></span> mice following transfection with control siRNAs (UNC) or specific siRNAs targeting <span class="html-italic">Ehmt2</span>. A significant reduction in Ehmt2 was observed with all the siRNA candidates relative to the control; (<b>b</b>) gene expression of <span class="html-italic">Snord116HG</span> following transfection with control siRNAs (UNC) or specific siRNAs targeting <span class="html-italic">Ehmt2</span>. <span class="html-italic">Eif4a2</span> was used as a control. Student’s <span class="html-italic">t</span> test: ****, <span class="html-italic">p</span> &lt; 0.0001; data represent means ± S.E.M from four biological replicates.</p>
Full article ">Figure 3
<p>Expression levels of <span class="html-italic">EHMT2</span>, <span class="html-italic">SNRPN</span>, and <span class="html-italic">SNORD116</span> after transfection with U6 anti-<span class="html-italic">EHMT2</span> shRNA DNA plasmids: (<b>a</b>) HEK293 cells were transfected with a plasmid construct control (shRNA Scramble) and shRNA specifically targeting <span class="html-italic">EHMT2</span>. A significant reduction in EHMT2 expression was observed with all the shRNA plasmid candidates relative to the control; (<b>b</b>) PWS UPD iPSC was transfected with the plasmid control and shRNA targeting <span class="html-italic">EHMT2</span>. A moderate but significant reduction in EHMT2 expression was observed 72 h post transfection; (<b>c</b>) <span class="html-italic">SNRPN</span> and <span class="html-italic">SNORD116</span> expression levels in PWS UPD iPSC remained at the same level as for the control after transfection with U6shRNA plasmids targeting <span class="html-italic">EHTM2</span>. Student’s <span class="html-italic">t</span> test: *, <span class="html-italic">p</span> &lt; 0.05; ***, <span class="html-italic">p</span> &lt; 0.001; ****, <span class="html-italic">p</span> &lt; 0.0001; data represent the means ± S.E.M from three biological replicates.</p>
Full article ">Figure 4
<p>Expression levels of <span class="html-italic">EHMT2</span>, <span class="html-italic">SNRPN</span> and <span class="html-italic">SNORD116</span> in UPD iPSC-derived neurons transduced with lentivirus containing anti-<span class="html-italic">EHMT2</span> shRNA or control (Scramble): (<b>a</b>) NILV-U6shRNA(h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-14) significantly reduced <span class="html-italic">EHMT2</span> RNA levels as opposed to a mild reduction with NILV-U6shRNA (h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-11) 7 days post transduction; <span class="html-italic">EHMT2</span> expression is further reduced 14 days post transduction with NILV-U6shRNA (h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-11). (<b>b</b>) NILV-U6shRNA (h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-11) significantly increased <span class="html-italic">SNRPN</span> and <span class="html-italic">SNORD116</span> transcript levels 7 days post transduction, as opposed to no change 14 days post transduction. There is a significant increase in SNRPN transcripts levels without any change in <span class="html-italic">SNORD116</span> transcripts levels 7 days post transduction with NILV-U6shRNA (h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-14). Student’s <span class="html-italic">t</span> test: *, <span class="html-italic">p</span> &lt; 0.05; **, <span class="html-italic">p</span> &lt; 0.01; ***, <span class="html-italic">p</span> &lt; 0.001; ****, <span class="html-italic">p</span> &lt; 0.0001; ns, <span class="html-italic">p</span> &gt; 0.05; data represent the means ± S.E.M of four biological replicates.</p>
Full article ">Figure 5
<p>Expression levels of <span class="html-italic">EHMT2, MAGEL2, SNRPN</span>, and <span class="html-italic">SNORD116</span> in SD-iPSC-derived neurons transduced with lentivirus with shRNA targeting <span class="html-italic">EHMT2</span> and control (Scramble): (<b>a</b>) NILV-U6shRNA(h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-14) and NILV-U6shRNA (h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-11) significantly reduced <span class="html-italic">EHMT2</span> RNA levels 7 days post transduction as opposed to a milder reduction 21 days post transduction; (<b>b</b>) NILV-U6shRNA (h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-11) significantly increased <span class="html-italic">SNRPN</span> transcript levels 7 days and 21 days post transduction as opposed to no change in <span class="html-italic">SNRPN</span> transcript levels 7 days and 21 days post transduction with NILV-U6shRNA(h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-14). A significant increase in SNORD116 transcripts levels is shown at day 7 post transduction with NILV-U6shRNA (h<span class="html-italic">EHMT2</span>/m<span class="html-italic">Ehmt2</span>-11). Student’s <span class="html-italic">t</span> test; *, <span class="html-italic">p</span> &lt; 0.05; **, <span class="html-italic">p</span> &lt; 0.01; ****, <span class="html-italic">p</span> &lt; 0.0001; ns, <span class="html-italic">p</span> &gt; 0.05; data represent the means ± S.E.M from four biological replicates.</p>
Full article ">
21 pages, 3907 KiB  
Article
Synthesis and Bioevaluation of New Stable Derivatives of Chrysin-8-C-Glucoside That Modulate the Antioxidant Keap1/Nrf2/HO-1 Pathway in Human Macrophages
by Javier Ávila-Román, Lirenny Quevedo-Tinoco, Antonio J. Oliveros-Ortiz, Sara García-Gil, Gabriela Rodríguez-García, Virginia Motilva, Mario A. Gómez-Hurtado and Elena Talero
Pharmaceuticals 2024, 17(10), 1388; https://doi.org/10.3390/ph17101388 - 17 Oct 2024
Viewed by 1079
Abstract
Background/Objectives: The beneficial effects of the flavonoid chrysin can be reduced by its poor oral bioavailability. It has been shown that chrysin-8-C-glucoside (1) has a better absorption capability. The aim of this study was to evaluate the antioxidant and anti-inflammatory [...] Read more.
Background/Objectives: The beneficial effects of the flavonoid chrysin can be reduced by its poor oral bioavailability. It has been shown that chrysin-8-C-glucoside (1) has a better absorption capability. The aim of this study was to evaluate the antioxidant and anti-inflammatory activity of this glucoside, as well as the respective hexa-acetate derivative 1a and the hexa-ethyl carbonate derivative 1b since the inclusion of moieties in bioactive molecules may increase or modify their biological effects. Methods: THP-1 macrophages were used to determine the viability in the presence of chrysin derivatives, and non-cytotoxic concentrations were selected. Subsequently, lipopolysaccharide (LPS)-induced reactive oxygen species (ROS) production and inflammatory mediators were examined. The involvement of chrysin derivatives with the Keap1 and Nrf2 antioxidant system was determined by docking and Western blotting studies. Results: Our data demonstrated, for the first time, that pretreatment with the three compounds caused a significant reduction in LPS-induced reactive oxygen species (ROS) production and pro-inflammatory cytokines tumor necrosis factor alpha (TNF-α) and interleukin 1β (IL-1β) levels, as well as in cyclooxygenase 2 (COX-2) expression. The mechanisms underlying these protective effects were related, at least in part, to the competitive molecular interactions of these phenolic compounds with Kelch-like ECH-associated protein 1 (Keap1)–nuclear factor erythroid 2-related factor 2 (Nrf2), which would allow the dissociation of Nrf2 and its translocation into the nucleus and the subsequent up-regulation of hemo-oxygenase 1 (HO-1) expression. Conclusions: Compared to the 8-C-glucoside parent chrysin, compound 1a exhibited the strongest antioxidant and anti-inflammatory activity. We hypothesized that the incorporation of an acetate group (1a) may reduce its polarity and, thus, increase membrane permeability, leading to better pharmacological activity. These findings support the potential use of these phenolic compounds as Nrf2 activators against oxidative-stress-related inflammatory diseases. Full article
(This article belongs to the Section Pharmacology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Formulas of chrysin-8-<span class="html-italic">C</span>-glucoside (<b>1</b>) and the respective hexa-acetate derivative (<b>1a</b>) and the hexa-ethyl carbonate derivative (<b>1b</b>).</p>
Full article ">Figure 2
<p>Effect of phenolics <b>1</b>, <b>1a</b>, and <b>1b</b> on the intracellular ROS production in THP-1 macrophages stimulated by LPS. These cells were treated with concentrations of 50 and 100 µM for compounds <b>1</b> and <b>1b</b> and 5 and 10 µM for compound <b>1a</b> for 1 h and then stimulated with 1 µg/mL LPS for 24 h. The positive reference drug dexamethasone (Dex) was used at 1 µM. Phenolics reduced the intracellular ROS production in a concentration-dependent manner even below Control levels at the higher tested concentrations. Values are representative of four independent experiments (<span class="html-italic">n</span> = 4). Data are arithmetic means ± SEM plotted by vertical bars. Mean value was significantly different vs. Control (++ <span class="html-italic">p</span> &lt; 0.01; Student’s <span class="html-italic">t</span> test). Arithmetic mean values were significantly different in comparison with LPS (* <span class="html-italic">p</span> &lt; 0.05, *** <span class="html-italic">p</span> &lt; 0.001; Kruskal–Wallis test followed by Dunn’s Multiple Comparison test.</p>
Full article ">Figure 3
<p>Effect of phenolics <b>1</b>, <b>1a,</b> and <b>1b</b> on LPS-induced TNF-α (<b>A</b>) and IL-1β (<b>B</b>) production in THP-1 macrophages. These cells were treated with the concentrations of 10, 50 and 100 µM for the compounds <b>1</b> and <b>1b</b> and 1, 5, and 10 µM for the compound <b>1a</b>, for 1 h and then stimulated with 1 µg/mL LPS for 24 h. Cytokines were quantified in cellular supernatants by using ELISA assay. The positive reference drug dexamethasone (Dex) was used at 1 μM. Values are arithmetic means ± SEM from six independent experiments (<span class="html-italic">n</span> = 6). Data are arithmetic means ± SEM plotted by vertical bars. Mean value was significantly different vs. Control (+++ <span class="html-italic">p</span> &lt; 0.001; Student’s <span class="html-italic">t</span> test). Arithmetic mean values were significantly different in comparison with LPS group (* <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001; one-way ANOVA followed by Bonferroni’s Multiple Comparison test).</p>
Full article ">Figure 4
<p>Effect of phenolics <b>1</b>, <b>1a</b>, and <b>1b</b> on the pro-inflammatory <span class="html-italic">COX-2</span> expression and the <span class="html-italic">Nrf2/HO-1</span> signaling pathway in THP-1 macrophages stimulated by LPS. These cells were treated with concentrations of 10, 50, and 100 µM for compounds <b>1</b> and <b>1b</b> and 1, 5, and 10 µM for compound <b>1a</b> for 1 h and then stimulated with 1 µg/mL LPS for 24 h. The positive reference drug dexamethasone (Dex) was used at 1 μM. (<b>A</b>) Representative Western blotting analysis of COX-2, Nrf2, and HO-1 proteins from the same membrane. Densitometric analysis of COX-2 (<b>B</b>), Nrf2 (<b>C</b>), and HO-1 (<b>D</b>) carrying out normalization to β-actin. Results are representative of four independent experiments (<span class="html-italic">n</span> = 4). Values are arithmetic means ± SEM plotted by vertical bars. Arithmetic mean value was significantly different vs. Control (+++ <span class="html-italic">p</span> &lt; 0.001, ++ <span class="html-italic">p</span> &lt; 0.01; Student’s <span class="html-italic">t</span> test). Arithmetic mean values were significantly different in comparison with the LPS group (* <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001; Kruskal–Wallis test followed by Dunn’s Multiple Comparison test).</p>
Full article ">Figure 5
<p>Molecular interactions of compounds <b>1</b>, <b>1a</b>, and <b>1b</b> with Keap1 calculated by docking protocols. The protein data (PDB ID: 4ZY3) were extracted from the Protein Data Bank website (<a href="https://www.rcsb.org/" target="_blank">https://www.rcsb.org/</a>). The docking protocol included the UCSF Quimera 1.15, Autodock Tools 1.5.6, and AutoDock Vina software. The molecular models of ligands <b>1</b>, <b>1a</b>, and <b>1b</b> involved in the docking study were geometry-optimized global minimum conformers, which were found by the Monte Carlo search protocol in the MMFF94 force field, as executed in the Spartan’04 program, followed by geometry optimization by the DFT B3LYP/DGDZVP level of theory in the Gaussian 16 software. (<b>A</b>) One pose was determined for glucoside flavonoid <b>1</b>, while two poses were found for derivative <b>1a</b> represented by (<b>B</b>) <b>1a</b>P1 and (<b>C</b>) <b>1a</b>P2. Compound <b>1b</b> showed three poses including (<b>D</b>) <b>1b</b>P1, (<b>E</b>) <b>1b</b>P2, and (<b>F</b>) <b>1b</b>P3.</p>
Full article ">Figure 6
<p>Docking models of compound <b>1</b>. The <b>left</b> image shows the Kelch domain of Keap1, which is a segment of the protein constituted by the 6-bladed <span class="html-italic">β</span>-propeller structure interacting with compound <b>1</b>. The <b>right</b> image shows the rings A and B from the flavonoid skeleton providing recurrent molecular interactions with Ala556, Arg415, and Asn382 amino acids from Keap1.</p>
Full article ">Figure 7
<p>Proposed diagram for the anti-inflammatory activity of phenolics <b>1</b>, <b>1a</b>, and <b>1b</b> through the interaction with the Keap1/Nrf2/HO-1 signaling pathway. In homeostatic conditions, the Keap1–Nrf2 system is placed joined to the cell’s internal hemimembrane. In these conditions, inactive Nrf2 is occasionally ubiquitinated and is degraded in the proteosome. In oxidative conditions, the intracellular ROS production and the inflammatory process are triggered, and the Nrf2 signaling pathway may be activated to control ROS-induced damage. Then, Nrf2 is dissociated from the Keap1 dimer and migrates into the nucleus to provide the transcription of its target gene, HO-1. This fact leads to the down-regulation of ROS production and inflammatory processes by inhibiting TNF-α, IL-1β, and COX-2 levels. In oxidative stress conditions, phenolics <b>1</b>, <b>1a</b>, and <b>1b</b> may be incorporated into the cell and act as Keap1 ligands, causing Nrf2 not to bind to or dissociate from Keap1, leading to further Nrf2 activation.</p>
Full article ">Figure 8
<p>Methodology for the obtention and chemical characterization of <b>1</b>, <b>1a</b>, and <b>1b</b>.</p>
Full article ">
13 pages, 2756 KiB  
Article
Resistance Analysis of a Soybean Cultivar, Nongqing 28 against Soybean Cyst Nematode, Heterodera glycines Ichinohe 1952
by Changjun Zhou, Yanfeng Hu, Yingpeng Han, Gang Chen, Bing Liu, Jidong Yu, Yaokun Wu, Jianying Li, Lan Ma and Jian Wei
Agronomy 2024, 14(9), 1964; https://doi.org/10.3390/agronomy14091964 - 30 Aug 2024
Viewed by 1107
Abstract
The soybean cyst nematode (SCN), Heterodera glycines Ichinohe, 1952, is one of the most destructive plant-parasitic nematodes in soybean production worldwide. The use of resistant soybean is the most effective alternative for its management. However, SCN-resistant soybean cultivars with increased yield and favorable [...] Read more.
The soybean cyst nematode (SCN), Heterodera glycines Ichinohe, 1952, is one of the most destructive plant-parasitic nematodes in soybean production worldwide. The use of resistant soybean is the most effective alternative for its management. However, SCN-resistant soybean cultivars with increased yield and favorable agronomic traits remain limited in the market. Here, we developed a new SCN-resistant soybean cultivar Nongqing 28 from the cross of the female parent cultivar An 02-318 and a male parent line F2 (Hei 99-980 × America Xiaoheidou). Resistance evaluation suggested that Nongqing 28 displayed stable resistance to SCN race 3 in pot assays and the 5-year field experiments, including inhibition of SCN development and reduction in female and cyst numbers. The average yields of Nongqing 28 were 2593 kg/ha and 2660 kg/ha in the 2-year regional trails and the 1-year production trials, with a yield increase of 6.2% and 8.1% compared with the local cultivar Nengfeng 18, respectively. The average seed fat contents in Nongqing 28 reached 21.26%. Additionally, RNA-seq analysis revealed that the resistance of Nongqing 28 to SCN infection is involved in pathogen perception and defense activation, such as reactive oxygen species burst, calcium-mediated defense signaling, hormonal signaling, the MAPK signaling cascade, and phenylpropanoid biosynthesis. In summary, this study provides a detailed characterization of a novel SCN-resistant soybean cultivar with high oil and yield potential. Full article
(This article belongs to the Special Issue Functional Genomics and Molecular Breeding of Soybeans)
Show Figures

Figure 1

Figure 1
<p>Pedigree chart of soybean cultivar Nongqing 28. An 02-318 derived from Hartwig is resistant to soybean cyst nematode (SCN), but Hei 99-980 and America Xiaoheidou are susceptible to SCN.</p>
Full article ">Figure 2
<p>The phenotypes and seeds of soybean cultivar Nongqing 28 in maturity stage.</p>
Full article ">Figure 3
<p>The comparable development of soybean cyst nematode on roots of Nongqing28, PI 437654, and Hefeng 50 at 5 and 10 days post inoculation (dpi). * denotes J2, and ** denotes J3. Scale bar = 500 µm.</p>
Full article ">Figure 4
<p>Transcriptome response of Nongqing 28 to soybean cyst nematode at 10 days post inoculation (dpi). (<b>A</b>) The number of differentially expressed genes (DEGs). (<b>B</b>) Volcano plots indicating all soybean genes of Nongqing 28 at 10 dpi. The red and green dots represent up- and downregualted genes. (<b>C</b>) Top 30 enriched Gene Ontology (GO) biological processes (BP) of the upregulated DEGs. (<b>D</b>) Top 20 most enriched KEGG terms of upregulated DEGs.</p>
Full article ">Figure 5
<p>Validation of DEGs in Nongqing 28 and Hefeng 50 at 10 dpi by quantity reverse transcription RT-qPCR. The expression levels of target genes are relative to the level of expression of soybean genes in the non-inoculated control plants using <span class="html-italic">GmUBQ3</span> as reference gene. The data are presented as the means of three replicates ± SE. Asterisks indicate a statistically significant difference between soybeans genes in SCN-infected plants and the non-infected control plants (Student’s <span class="html-italic">t</span>-test, * <span class="html-italic">p</span> &lt; 0.5).</p>
Full article ">
Back to TopTop